Serum Institute applies for trials of another COVID-19 vaccine
PTI, Jan 30, 2021, 4:28 PM IST
Pune: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said his company has applied to start the trials of another COVID-19 vaccine and that it hopes to launch it by June 2021.
The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca. The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive.
In a tweet, Poonawalla said, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!”
The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world’s largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Vice President, Prime Minister pay tributes to Saint Ravidas on his birth anniversary
India extends restrictions on international passenger flights till March 31
Maha board exams for Classes 12, 10 to begin on April 23, 29
Delhi Police ASI shoots himself dead inside PCR van
India has one DNA and it is Hindu: RSS leader
MUST WATCH
Latest Additions
Vice President, Prime Minister pay tributes to Saint Ravidas on his birth anniversary
India extends restrictions on international passenger flights till March 31
Mangaluru: Sale of seized luxury car in police custody; CID begins probe
Maha board exams for Classes 12, 10 to begin on April 23, 29
M’luru City Corp’s contract worker files harassment complaint against officials